First report of Tsukamurella endocarditis in an immunocompromised patient receiving chemotherapy

Tsukamurella spp. are gram-positive rods that can be isolated from the environment in soil and moist areas. In rare instances, they are known to cause infections in immunocompromised hosts. We present the first reported case of Tsukamurella endocarditis in an immunocompromised patient who was succes...

Full description

Saved in:
Bibliographic Details
Published in:European journal of clinical microbiology & infectious diseases 2020-10, Vol.39 (10), p.1989-1991
Main Authors: Malik, Zain, Shah, Punit J., Tariq, Farheen
Format: Article
Language:English
Subjects:
Actinobacteria - genetics
Actinobacteria - isolation & purification
Anti-Bacterial Agents - administration & dosage
Anti-Bacterial Agents - therapeutic use
Antineoplastic Agents - therapeutic use
Biomedical and Life Sciences
Biomedicine
Brief Report
Chemotherapy
Diagnosis, Differential
Endocarditis
Endocarditis, Bacterial - diagnosis
Endocarditis, Bacterial - drug therapy
Endocarditis, Bacterial - microbiology
Female
Humans
Imipenem
Imipenem - administration & dosage
Imipenem - therapeutic use
Immunocompromised Host
Immunocompromised hosts
Internal Medicine
Lung Neoplasms - drug therapy
Medical Microbiology
Middle Aged
Small Cell Lung Carcinoma - drug therapy
Soil moisture
Sulfamethoxazole
Trimethoprim
Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage
Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use
Trimethoprim-sulfamethoxazole
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Tsukamurella spp. are gram-positive rods that can be isolated from the environment in soil and moist areas. In rare instances, they are known to cause infections in immunocompromised hosts. We present the first reported case of Tsukamurella endocarditis in an immunocompromised patient who was successfully treated with a 6-week course of imipenem and trimethoprim-sulfamethoxazole.
ISSN:0934-9723
1435-4373
DOI:10.1007/s10096-020-03917-5